Laizer Kornwasser, EVP, Company Group Chairman at Valeant Pharmaceuticals International, Inc. (VRX), bought 3,500 shares at $100.36 ($351K) on 2013-08-09, disclosed to the SEC on 2013-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TDOC | SELL | 2024-05-02 | $264K | — | Filing → |
| TDOC | SELL | 2024-03-05 | $533K | — | Filing → |
| TDOC | SELL | 2024-02-02 | $302K | — | Filing → |